Danaher Corp., US2358511028

Danaher Corp stock at EUR 191.93 with USD 150.9 billion market cap

Published on 10/08/2026 at 19:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Danaher Corp stock costs EUR 191.93 on October 8, 2026 after EUR 195.18. Market value is USD 150.9 billion and P/E is 38.2.

Key points in brief

  • Danaher Corp stock was EUR 191.93 at Lang & Schwarz on October 8, 2026, down 1.67 percent from EUR 195.18.
  • The USD 150.9 billion company had a P/E ratio of 38.2 and a USD 160.93 to USD 242.80 52-week range.
  • Barclays raised its Danaher target from USD 230.00 to USD 255.00, while third-quarter results are scheduled for October 21, 2026.
Pop-Art-Comic einer begeisterten Wissenschaftlerin mit leuchtendem Reagenzglas im Retro-Halftone-Stil
Danaher Corp. Life-Sciences-Entdeckung US2358511028 als bunter Pop-Art-Comic mit Forscherin und leuchtendem Reagenzglas, Illustration mit AI erstellt.

Danaher Corp stock was trading at EUR 191.93 at Lang & Schwarz on October 8, 2026 at 7:12 p.m. CEST, down 1.67 percent from the prior close of EUR 195.18. The bid was EUR 191.80 and the ask EUR 192.05, placing the after-hours quote below the previous Lang & Schwarz close.

Price sits within a wide range

On the NYSE, Danaher was last at USD 214.71 on October 8, 2026 at 1:25 p.m. ET. The USD 160.93 to USD 242.80 52-week range puts the home-market quote between its annual low and high, while the latest volume was 3,130,743 shares against an average of 4,702,246.

The market capitalization was USD 150.9 billion on October 8, 2026. The P/E ratio was 38.2 and the trailing dividend yield was 0.01 percent, giving the valuation paragraph a clear earnings and income reference.

Barclays lifts its target

According to MarketBeat on October 7, 2026, Barclays raised its Danaher price target from USD 230.00 to USD 255.00 while maintaining an overweight rating. The new target is 18.76 percent above the NYSE price of USD 214.71, calculated in the same currency.

The same MarketBeat report listed a Moderate Buy consensus and an average target of USD 235.23. That average target is 9.56 percent above the NYSE price, a smaller gap than Barclays' new objective.

Comparison with peers

Danaher Corp.: minus 1.67 percent, P/E 38.2, market capitalization USD 150.9 billion
Thermo Fisher Scientific (NYSE, USD): minus 2.67 percent, P/E 34.7, market capitalization USD 238.2 billion
Agilent Technologies (NYSE, USD): minus 1.81 percent, P/E 32.7, market capitalization USD 46.9 billion

Next results date is October 21

Danaher scheduled its third-quarter 2026 earnings conference call for October 21, 2026 at 8:00 a.m. ET. The date gives the valuation figures a defined calendar point for the next financial update.

After-hours quote remains below prior close

Danaher's euro quote was EUR 191.93 at Lang & Schwarz on October 8, 2026 at 7:12 p.m. CEST, versus EUR 195.18 at the prior close, while the NYSE quote was USD 214.71 at 1:25 p.m. ET. The further course of trading is shown by the continuously updated real-time quote of Danaher Corp stock.

Danaher Corp stock facts

  • Company: Danaher Corporation
  • ISIN: US2358511028
  • Ticker: DHR
  • Primary exchange: NYSE
  • Price Lang & Schwarz as of October 8, 2026, 7:12 p.m. CEST: EUR 191.93
  • Change versus prior close: minus 1.67 percent
  • Prior close Lang & Schwarz October 7, 2026: EUR 195.18
  • Market capitalization: USD 150.9 billion as of October 8, 2026
  • 52-week range: USD 160.93-242.80 as of October 8, 2026
  • Next earnings date: October 21, 2026

Market context: Market report S&P 500.

More news and analyses on Danaher Corp stock

Disclaimer...

en | US2358511028 | DANAHER CORP. | boerse | 70269433 | bgmi